TRANSLATE

Thursday, 20 September 2018

BREAKING NEWS:

NICE have issued draft guidance concluding that the CAR-T cell therapy Kymriah® is too expensive to recommend as a treatment for adults with lymphoma.

 
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)